| scholarly article | Q13442814 |
| P356 | DOI | 10.1210/JC.2013-3628 |
| P698 | PubMed publication ID | 24471573 |
| P50 | author | Gérald Raverot | Q38546156 |
| Frederic Castinetti | Q39453225 | ||
| Thierry Brue | Q40173582 | ||
| Bernard Goichot | Q53242962 | ||
| Jérome Bertherat | Q57014579 | ||
| Philippe Chanson | Q58441504 | ||
| Marie-Christine Vantyghem | Q58509777 | ||
| Olivier Chabre | Q72940457 | ||
| Jacques Young | Q79281866 | ||
| Antoine Tabarin | Q88750979 | ||
| Delphine Vezzosi | Q89737457 | ||
| Delphine Drui | Q90939729 | ||
| Brigitte Delemer | Q97591051 | ||
| Laurence Guignat | Q114429756 | ||
| Melanie Philippon | Q114429757 | ||
| Isabelle Morange | Q114429758 | ||
| Bernard Conte-Devolx | Q114429759 | ||
| Monique Martinie | Q114429760 | ||
| Sophie Christin-Maitre | Q114429761 | ||
| Camille Baudry | Q114779442 | ||
| P2093 | author name string | Philippe Caron | |
| Marie Muller | |||
| Laurent Quinquis | |||
| Peter Kamenicky | |||
| Bruno Donadille | |||
| Maelle Le Bras | |||
| Emmanuelle Motte | |||
| Fiorina Luca | |||
| Helene Bihan | |||
| Pauline Giraud | |||
| P433 | issue | 5 | |
| P921 | main subject | Cushing's disease | Q1947304 |
| P304 | page(s) | 1623-1630 | |
| P577 | publication date | 2014-01-28 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Ketoconazole in Cushing's disease: is it worth a try? | |
| P478 | volume | 99 |
| Q38667419 | 5th International ACC Symposium: Old Syndromes with New Biomarkers and New Therapies with Old Medications. |
| Q92343115 | A Case of Severe Psychosis Due to Cushing's Syndrome Secondary to Primary Bilateral Macronodular Adrenal Hyperplasia |
| Q38407849 | Adrenocortical carcinoma, an unusual cause of secondary hypertension. |
| Q90391968 | Advances in the medical treatment of Cushing's syndrome |
| Q38310473 | Bilateral adrenalectomy for Cushing's disease |
| Q26770396 | Bilateral adrenalectomy in the 21st century: when to use it for hypercortisolism? |
| Q51092138 | CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 Mutations. |
| Q90612345 | Cardiovascular risk and mortality in patients with active and treated hypercortisolism |
| Q58789954 | Cell Cycle Regulators and Lineage-Specific Therapeutic Targets for Cushing Disease |
| Q35260959 | Clinical Guidelines for the Diagnosis and Treatment of Cushing's Disease in Korea |
| Q26858933 | Clinical use of pasireotide for Cushing's disease in adults |
| Q38833981 | Complications of Cushing's syndrome: state of the art. |
| Q88652839 | Cushing's Syndrome in Pediatrics: An Update |
| Q28071635 | Cushing's disease: a multidisciplinary overview of the clinical features, diagnosis, and treatment |
| Q28262360 | Cushing's syndrome |
| Q35531889 | Cushing's syndrome: epidemiology and developments in disease management |
| Q55425212 | Diabetes Mellitus Secondary to Cushing's Disease. |
| Q47224599 | Dimethoxy-etomidate: A Non-hypnotic Etomidate Analog that Potently Inhibits Steroidogenesis |
| Q33571585 | Drug Interaction Potential of Osilodrostat (LCI699) Based on Its Effect on the Pharmacokinetics of Probe Drugs of Cytochrome P450 Enzymes in Healthy Adults |
| Q33569920 | Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients |
| Q56957557 | Effectiveness of medical treatment for Cushing's syndrome: a systematic review and meta-analysis |
| Q42696417 | Effects of Ketoconazole on the Pharmacokinetics of Mifepristone, a Competitive Glucocorticoid Receptor Antagonist, in Healthy Men. |
| Q90201781 | Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing's syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial |
| Q98171269 | Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a doubleblind, randomised withdrawal phase |
| Q53087307 | Evaluation of Evidence of Adrenal Insufficiency in Trials of Normocortisolemic Patients Treated With Mifepristone. |
| Q36555164 | Fluconazole in the treatment of Cushing's disease |
| Q92363961 | Fluconazole treatment in severe ectopic Cushing syndrome |
| Q93063035 | Functioning Pituitary Adenomas - Current Treatment Options and Emerging Medical Therapies |
| Q38683309 | Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly |
| Q92983059 | Long-term efficacy and safety of once-monthly pasireotide in Cushing's disease: A Phase III extension study |
| Q34635993 | Long-term low-dose ketoconazole treatment in bilateral macronodular adrenal hyperplasia |
| Q33840655 | Long-term treatment of Cushing's disease with pasireotide: 5-year results from an open-label extension study of a Phase III trial |
| Q64249996 | Low-dose etomidate for the management of severe hypercortisolaemia in different clinical scenarios: a case series and review of the literature |
| Q39168432 | Management of hormone-secreting pituitary adenomas |
| Q38342520 | Medical combination therapies in Cushing's disease |
| Q38307934 | Medical therapy for Cushing's disease: adrenal steroidogenesis inhibitors and glucocorticoid receptor blockers |
| Q90266248 | Metyrapone treatment in Cushing's syndrome: a real-life study |
| Q49173327 | Multiple Salivary Cortisol Measurements Are a Useful Tool to Optimize Metyrapone Treatment in Patients with Cushing's Syndromes Treatment: Case Presentations. |
| Q55249109 | New Insights in Cushing Disease Treatment With Focus on a Derivative of Vitamin A. |
| Q36704499 | Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing's disease |
| Q91558012 | Pituitary Adenomas: What Are the Key Features? What Are the Current Treatments? Where Is the Future Taking Us? |
| Q54250335 | Posaconazole-Induced Adrenal Insufficiency in a Case of Chronic Myelomonocytic Leukemia. |
| Q39420116 | Recent Progress in the Medical Therapy of Pituitary Tumors |
| Q52368761 | Repeat stereotactic radiosurgery for Cushing's disease: outcomes of an international, multicenter study. |
| Q92404214 | Safety and Efficacy of Subcutaneous Pasireotide in Patients With Cushing's Disease: Results From an Open-Label, Multicenter, Single-Arm, Multinational, Expanded-Access Study |
| Q90396537 | Sexual Dimorphism in Cellular and Molecular Features in Human ACTH-Secreting Pituitary Adenomas |
| Q92158273 | Surgical Outcomes and Comorbidities in Cushing Disease: 30 Years of Experience in a Referral Center |
| Q22000607 | Systemic therapy of Cushing's syndrome |
| Q90052692 | TREATMENT OF CUSHING'S SYNDROME : WHAT PLACE FOR MEDICAL TREATMENT? |
| Q56336660 | Technique of Whole-Sellar Stereotactic Radiosurgery for Cushing Disease: Results from a Multicenter, International Cohort Study |
| Q64986758 | The Pathophysiology and Treatment of Hypertension in Patients With Cushing's Syndrome. |
| Q36681083 | The Role of Isotretinoin Therapy for Cushing's Disease: Results of a Prospective Study |
| Q27010590 | The Treatment of Cushing's Disease |
| Q92699881 | The Treatment of Refractory Pituitary Adenomas |
| Q90201779 | The sinister side of Cushing's therapy |
| Q38718807 | Therapeutic Strategies for the Treatment of Severe Cushing's Syndrome. |
| Q35916555 | Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline |
| Q38545050 | USP8: a novel therapeutic target for Cushing's disease. |
| Q33802284 | Update on medical treatment for Cushing's disease |
| Q28076013 | Updates on the role of adrenal steroidogenesis inhibitors in Cushing's syndrome: a focus on novel therapies |
Search more.